Chào mừng Bạn tham gia Diễn Đàn VNKienThuc.com - Định hướng Forum Kiến Thức
- HÃY TẠO CHỦ ĐỀ KIẾN THỨC HỮU ÍCH VÀ CÙNG NHAU THẢO LUẬN
Kết nối: VNK X - VNK groups | Nhà Tài Trợ: BhnongFood X - Bhnong groups - Đặt mua Bánh Bhnong

Trả lời chủ đề

Nội dung: <blockquote data-quote="bioideavn" data-source="post: 119570" data-attributes="member: 256467"><a href="https://www.mediafire.com/?hhb1tqj9pltwmtd" target="_blank">https://www.mediafire.com/?hhb1tqj9pltwmtd</a>pass diendankienthuc.netProstate cancer cells overexpress the measles virus (MV) receptor CD46. Herein, we evaluated the antitumor activity of an oncolytic derivative of the MV Edmonston (MV-Edm) vaccine strain engineered to express the human sodium iodide symporter (NIS; MV-NIS virus). MV-NIS showed significant cytopathic effect (CPE) against prostate cancer cell lines in vitro. Infected cells effectively concentrated radioiodide isotopes as measured in vitro by Iodide-125 ((125)I) uptake assays. Virus localization and spread in vivo could be effectively followed by imaging of (123)I uptake. In vivo administration of MV-NIS either locally or systemically (total dose of 9 x 10(6) TCID(50)) resulted in significant tumor regression (P < 0.05) and prolongation of survival (P < 0.01). Administration of (131)I further enhanced the antitumor effect of MV-NIS virotherapy (P < 0.05). In conclusion, MV-NIS is an oncolytic vector with significant antitumor activity against prostate cancer, which can be further enhanced by (131)I administration. The NIS transgene allows viral localization and monitoring by noninvasive imaging which can facilitate dose optimization in a clinical setting.</blockquote>